Previous 10 | Next 10 |
Zynex Announces a Second Utility Patent for Its Blood Volume Monitor PR Newswire ENGLEWOOD, Colo. , Jan. 6, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive med...
It's easier to find bargains in the stock market if you look at high-quality small-cap stocks because not many investors have an appetite for these lesser known names. For perspective, the Russell 2000 , an index tracking small-cap stocks, rose 18.4% in 2020, outperforming the S&...
Click here to read the previous top NASDAQ medical device stocks article. The growing prevalence of chronic diseases such as cancer and diabetes is driving increasing innovation in medical device technology . As of mid-December 2020, 49 new devices had been approve...
Zynex Ranked 13th in Revenue Growth Among Medical Device Companies PR Newswire ENGLEWOOD, Colo., Nov. 19, 2020 ENGLEWOOD, Colo., Nov. 19, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufa...
Zynex to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference PR Newswire ENGLEWOOD, Colo., Nov. 17, 2020 ENGLEWOOD, Colo., Nov. 17, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializ...
Zynex, Inc. (ZYXI) Q3 2020 Earnings Conference Call October 27, 2020 4:15 PM ET Company Participants Thomas Sandgaard - Founder, Chairman, and Chief Executive Officer Dan Moorhead - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Yi Chen - HC Wainwright...
Image source: The Motley Fool. Zynex, Inc (NASDAQ: ZYXI) Q3 2020 Earnings Call Oct 27, 2020 , 4:15 p.m. ET Operator Continue reading For further details see: Zynex, Inc (ZYXI) Q3 2020 Earnings Call Transcript
Zynex (ZYXI): Q3 GAAP EPS of $0.04 misses by $0.01.Revenue of $20M (+69.2% Y/Y) misses by $0.76M.FY revenue guidance is $80-$81M, up +77% Y/Y.Shares -3.5%.Press Release For further details see: Zynex EPS misses by $0.01, misses on revenue
Zynex Announces Third Quarter 2020 Earnings PR Newswire ENGLEWOOD, Colo., Oct. 27, 2020 ENGLEWOOD, Colo. , Oct. 27, 2020 /PRNewswire/ -- Revenue increased 69% year over year to $20.0 million Orders increased 96% Net inc...
Zynex (ZYXI) hires Neil Friery as the President and COO of its Monitoring Solutions Division.Thomas Sandgaard, founder and CEO said: "I am excited to bring Neil in to run our Monitoring Solutions Division. We continue to build out this division, adding personnel in clinical res...
News, Short Squeeze, Breakout and More Instantly...
Zynex Reports Second Quarter 2024 Financial Results PR Newswire Q2 2024 Revenue Increased 11% to $49.9 Million ENGLEWOOD, Colo. , July 25, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the ma...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...